201 related articles for article (PubMed ID: 14202020)
1. THE QUANTITATIVE DETERMINATION OF FIBRINOLYTIC INHIBITORS IN PLASMA OR SERUM BY MEANS OF THE FIBRIN PLATE.
BLIX S
Scand J Clin Lab Invest; 1964; 16():403-8. PubMed ID: 14202020
[No Abstract] [Full Text] [Related]
2. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
JACOBSEN CD
Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
[No Abstract] [Full Text] [Related]
3. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
GODAL HC; HELLE I
Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
[No Abstract] [Full Text] [Related]
4. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
BRAKMAN P; ASTRUP T
Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
[No Abstract] [Full Text] [Related]
5. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
TYLER HM; LACK CH
Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
[No Abstract] [Full Text] [Related]
6. [STUDIES ON THE CONDITIONS FOR THE FORMATION OF URINARY CYLINDERS].
FREY J; JUERGENS J
Med Klin; 1964 Apr; 59():560-7. PubMed ID: 14197215
[No Abstract] [Full Text] [Related]
7. FIBRINOGEN BREAKDOWN PRODUCTS.
LEWIS JH; WILSON JH
Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
[No Abstract] [Full Text] [Related]
8. [LEUKOCYTIC FIBRINOLYSIS].
CAVIEZEL O; VOLLERY M; VANNOTTI A
Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603
[No Abstract] [Full Text] [Related]
9. ACTIVATION OF RABBIT PLASMINOGEN BY STREPTOKINASE.
CHATTOPADHYAY DP; CLIFFTON EE
Am J Physiol; 1965 Jan; 208():190-7. PubMed ID: 14253148
[No Abstract] [Full Text] [Related]
10. THE ANTIPLASMIN ACTIVITY OF HUMAN PLASMA AND SERUM AND ITS DEPENDENCE ON IONS.
JACOBSEN CD
Scand J Clin Lab Invest; 1964; 16():383-90. PubMed ID: 14202018
[No Abstract] [Full Text] [Related]
11. THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.
SWEET B; RIFKIND BM; MCNICOL GP
J Atheroscler Res; 1965; 5(3):347-50. PubMed ID: 14290298
[No Abstract] [Full Text] [Related]
12. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen].
GIACOMAZZI G
Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267
[No Abstract] [Full Text] [Related]
13. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
HIRATA T
Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
[No Abstract] [Full Text] [Related]
14. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR.
BRAKMAN P; KING AE
Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832
[No Abstract] [Full Text] [Related]
15. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
[No Abstract] [Full Text] [Related]
16. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
BIELAWIEC M; NILSSON IM
Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
[No Abstract] [Full Text] [Related]
17. [STREPTOKINASE INACTIVATION WITH POLYAMINOSTYROL].
CAVIEZEL O
Schweiz Med Wochenschr; 1964 Aug; 94():1194-8. PubMed ID: 14257919
[No Abstract] [Full Text] [Related]
18. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
HELLE I; AAS K; GODAL HC
Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
[No Abstract] [Full Text] [Related]
19. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
[No Abstract] [Full Text] [Related]
20. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
BLATT WF; GRAY JL; JENSEN H
Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
